2021
DOI: 10.1007/s00005-021-00618-5
|View full text |Cite
|
Sign up to set email alerts
|

CTLA-4 Expression and Its Clinical Significance in Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 68 publications
1
23
0
Order By: Relevance
“…We also observed high expression of the immune checkpoint regulator CTLA-4 in breast tumor infiltrates from the exposed patients. Literature reports some associations between CTLA-4 expression in the tumor microenvironment and worse outcomes [ 34 ], reaching more than 50% of cases [ 35 ]. Even though we did not find any specific study about the impact of pesticides on CTLA-4 expression and considering the IL-12 and TGF-β1-induced changes, exposure to such substances significantly affects the negative regulation of the immune environment of breast cancer patients.…”
Section: Discussionmentioning
confidence: 99%
“…We also observed high expression of the immune checkpoint regulator CTLA-4 in breast tumor infiltrates from the exposed patients. Literature reports some associations between CTLA-4 expression in the tumor microenvironment and worse outcomes [ 34 ], reaching more than 50% of cases [ 35 ]. Even though we did not find any specific study about the impact of pesticides on CTLA-4 expression and considering the IL-12 and TGF-β1-induced changes, exposure to such substances significantly affects the negative regulation of the immune environment of breast cancer patients.…”
Section: Discussionmentioning
confidence: 99%
“…CTLA-4 is an essential stimulatory receptor that regulates T-cell activation, which can reduce or eliminate immune cell function and encourage tumor cells to escape immune surveillance. Inhibition of CTLA-4 can eliminate immune tolerance and tumor cell proliferation ( Kern and Panis, 2021 ). The TMB represents the number of mutations per megabase (Mut/Mb) in specific cancer.…”
Section: Discussionmentioning
confidence: 99%
“…However, flow cytometry is faster and easier. Previous studies have shown that CTLA-4 expression levels are elevated in breast cancer patients [ 33 ], and the absence of CTLA-4 can cause dysregulation of the immune response [ 34 ]. Peng Pu-ji et al found that TIM-3 was highly expressed in pancreatic cancer tissues [ 35 ].…”
Section: Discussionmentioning
confidence: 99%